Yajing Feng
-
- Advanced Breast Cancer Therapies 5
- Brain Metastases and Treatment 3
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
-
- Cancer-related molecular mechanisms research 8
- MicroRNA in disease regulation 6
- Emergency Medical Services top 10%
- Modeling and Simulation top 10%
-
- Circular RNAs in diseases 6
-
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 5
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yajing Feng
28 papers receiving 546 citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Pulmonary and Respiratory Medicine 261
- Cancer Research 78
- Health 43
- Emergency Medical Services 35
- Modeling and Simulation 21
Countries citing papers authored by Yajing Feng
This map shows the geographic impact of Yajing Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yajing Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yajing Feng more than expected).
Fields of papers citing papers by Yajing Feng
This network shows the impact of papers produced by Yajing Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yajing Feng. The network helps show where Yajing Feng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yajing Feng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 7 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 8 | |
| 10 | 2020 | 17 | |
| 11 | 2020 | 60 | |
| 12 | 2019 | 12 | |
| 13 | 2019 | 4 | |
| 14 | 2019 | 11 | |
| 15 | 2018 | 2 | |
| 16 | 2017 | 12 | |
| 17 | 2016 | 7 | |
| 18 | 2016 | 2 | |
| 19 | 2016 | 8 | |
| 20 | [Toxicity evaluation on the effluent water from a sewage treatment plant in Zhengzhou City]. | 2011 | 1 |
About Yajing Feng
Yajing Feng is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 553 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (5 papers), Brain Metastases and Treatment (3 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (261 citations), Cancer Research (78 citations) and Health (43 citations). Yajing Feng has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ning Wang, Liwen Fang, Shu Cong, Baohua Wang, Heling Bao, Jing Fan, Yonghua Hu, Ke Lu, Pei Gao and Xun Tang.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.